Last updated on February 2018

Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression

Brief description of study

The study will evaluate the efficacy and safety of ITI-007 in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.

Clinical Study Identifier: NCT02600494

Contact Investigators or Research Sites near you

Start Over

Kimberly Vanover, Ph.D.

Clinical Site
Cedarhurst, NY United States
  Connect »